Digostics At-Home Type 1 Diabetes Test Trialed In Children For Routine UK NHS Use

Home Test Could ‘Reduce The Burden Of Testing’

Researchers from the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Center are testing Digostics’ GTT@home test in children to assess if it offers a better alternative to the clinical gold-standard oral glucose tolerance test.

Finger-prick diabetes
(Shutterstock)

At-home testing for type 1 diabetes in children will be investigated in a new trial led by researchers at the UK National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Center. The Nuffield Department of Medicine’s Centre for Human Genetics is co-leading the study.

The GTT@home test, developed by Oxford, UK-based diagnostic startup Digostics, will be tested in 90 children and young people. The trial will determine whether at-home type 1 diabetes testing could...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from Market Intelligence